Terms: = Germ cell tumor AND TCF3, E2A, 6929, ENSG00000071564, P15923, MGC129648, MGC129647, ITF1
24 results:
1. Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.
Lim-Fat MJ; Iorgulescu JB; Rahman R; Bhave V; Muzikansky A; Woodward E; Whorral S; Allen M; Touat M; Li X; Xy G; Patel J; Gerstner ER; Kalpathy-Cramer J; Youssef G; Chukwueke U; McFaline-Figueroa JR; Nayak L; Lee EQ; Reardon DA; Beroukhim R; Huang RY; Bi WL; Ligon KL; Wen PY
Clin Cancer Res; 2024 Apr; 30(7):1327-1337. PubMed ID: 38252427
[TBL] [Abstract] [Full Text] [Related]
2. Transcriptome Changes in Glioma cells Cultivated under Conditions of Neurosphere Formation.
Vasileva NS; Kuligina EV; Dymova MA; Savinovskaya YI; Zinchenko ND; Ageenko AB; Mishinov SV; Dome AS; Stepanov GA; Richter VA; Semenov DV
Cells; 2022 Oct; 11(19):. PubMed ID: 36231068
[TBL] [Abstract] [Full Text] [Related]
3. tcf3 Induces DNMT1 Expression to Regulate Wnt Signaling Pathway in Glioma.
Zeng W; Jiang H; Wang Y; Wang C; Yu B
Neurotox Res; 2022 Jun; 40(3):721-732. PubMed ID: 35446002
[TBL] [Abstract] [Full Text] [Related]
4. PTBP1 is a Novel Poor Prognostic Factor for Glioma.
Liu P; He GC; Tan YZ; Liu GX; Liu AM; Zhu XP; Zhou Y; Hu WM
Biomed Res Int; 2022; 2022():7590997. PubMed ID: 35299889
[TBL] [Abstract] [Full Text] [Related]
5. Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.
Bu L; Yang Q; McMahon L; Xiao GQ; Li F
Exp Mol Pathol; 2019 Oct; 110():104293. PubMed ID: 31381875
[TBL] [Abstract] [Full Text] [Related]
6. [New molecular pathological strategies for malignant iris tumors].
Kakkassery V; Jünemann AM; Scheef BO; Grisanti S; Heindl LM
Ophthalmologe; 2019 Apr; 116(4):324-331. PubMed ID: 30623224
[TBL] [Abstract] [Full Text] [Related]
7. Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
Prabhu VV; Lulla AR; Madhukar NS; Ralff MD; Zhao D; Kline CLB; Van den Heuvel APJ; Lev A; Garnett MJ; McDermott U; Benes CH; Batchelor TT; Chi AS; Elemento O; Allen JE; El-Deiry WS
PLoS One; 2017; 12(8):e0180541. PubMed ID: 28767654
[TBL] [Abstract] [Full Text] [Related]
8. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.
Busse TM; Roth JJ; Wilmoth D; Wainwright L; Tooke L; Biegel JA
Genes Chromosomes Cancer; 2017 Oct; 56(10):730-749. PubMed ID: 28597942
[TBL] [Abstract] [Full Text] [Related]
9. Transcription factor 3 controls cell proliferation and migration in glioblastoma multiforme cell lines.
Li R; Li Y; Hu X; Lian H; Wang L; Fu H
Biochem Cell Biol; 2016 Jun; 94(3):247-55. PubMed ID: 27105323
[TBL] [Abstract] [Full Text] [Related]
10. Deciphering the molecular basis of invasiveness in Sdhb-deficient cells.
Loriot C; Domingues M; Berger A; Menara M; Ruel M; Morin A; Castro-Vega LJ; Letouzé É; Martinelli C; Bemelmans AP; Larue L; Gimenez-Roqueplo AP; Favier J
Oncotarget; 2015 Oct; 6(32):32955-65. PubMed ID: 26460615
[TBL] [Abstract] [Full Text] [Related]
11. Melanoma survival is superior in females across all tumour stages but is influenced by age.
Khosrotehrani K; Dasgupta P; Byrom L; Youlden DR; Baade PD; Green AC
Arch Dermatol Res; 2015 Oct; 307(8):731-40. PubMed ID: 26103951
[TBL] [Abstract] [Full Text] [Related]
12. Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics.
Zheng X; Naiditch J; Czurylo M; Jie C; Lautz T; Clark S; Jafari N; Qiu Y; Chu F; Madonna MB
Cell Death Dis; 2013 Jul; 4(7):e740. PubMed ID: 23887631
[TBL] [Abstract] [Full Text] [Related]
13. E47 and Id1 interplay in epithelial-mesenchymal transition.
Cubillo E; Diaz-Lopez A; Cuevas EP; Moreno-Bueno G; Peinado H; Montes A; Santos V; Portillo F; Cano A
PLoS One; 2013; 8(3):e59948. PubMed ID: 23555842
[TBL] [Abstract] [Full Text] [Related]
14. Epithelial-mesenchymal transition-related gene expression as a new prognostic marker for neuroblastoma.
Nozato M; Kaneko S; Nakagawara A; Komuro H
Int J Oncol; 2013 Jan; 42(1):134-40. PubMed ID: 23135478
[TBL] [Abstract] [Full Text] [Related]
15. Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations.
Loriot C; Burnichon N; Gadessaud N; Vescovo L; Amar L; Libé R; Bertherat J; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP; Favier J
J Clin Endocrinol Metab; 2012 Jun; 97(6):E954-62. PubMed ID: 22492777
[TBL] [Abstract] [Full Text] [Related]
16. Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma.
Arab K; Smith LT; Gast A; Weichenhan D; Huang JP; Claus R; Hielscher T; Espinosa AV; Ringel MD; Morrison CD; Schadendorf D; Kumar R; Plass C
Carcinogenesis; 2011 Oct; 32(10):1467-73. PubMed ID: 21771727
[TBL] [Abstract] [Full Text] [Related]
17. tcf3 inhibits F9 embryonal carcinoma growth by the down-regulation of Oct4.
Lin G; Zhao L; Yin F; Lan R; Li L; Zhang X; Zhang H; Yang B
Oncol Rep; 2011 Oct; 26(4):893-9. PubMed ID: 21725619
[TBL] [Abstract] [Full Text] [Related]
18. Role of ES cell-expressed Ras (ERas) in tumorigenicity of gastric cancer.
Kubota E; Kataoka H; Aoyama M; Mizoshita T; Mori Y; Shimura T; Tanaka M; Sasaki M; Takahashi S; Asai K; Joh T
Am J Pathol; 2010 Aug; 177(2):955-63. PubMed ID: 20566745
[TBL] [Abstract] [Full Text] [Related]
19. Id1 overexpression is independent of repression and epigenetic silencing of tumor suppressor genes in melanoma.
Healey MA; Deaton SL; Alder JK; Winnepenninckx V; Casero RA; Herman JG
Epigenetics; 2010 Jul; 5(5):410-21. PubMed ID: 20484992
[TBL] [Abstract] [Full Text] [Related]
20. Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling.
Salins P; Shawesh S; He Y; Dibrov A; Kashour T; Arthur G; Amara F
Neurosci Lett; 2007 Feb; 412(3):211-6. PubMed ID: 17234346
[TBL] [Abstract] [Full Text] [Related]
[Next]
